1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_
2	to	_	_	TO	_	_	_	_	_
3	Tissue	_	_	NN	_	_	_	_	_
4	Engineering	_	_	NN	_	_	_	_	_
5	Scaffolds	_	_	NNS	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	Bottom-Up	_	_	NN	_	_	_	_	_
8	Fabrication	_	_	NN	_	_	_	_	_


1	Traumas	_	_	NNS	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	diseases	_	_	NNS	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	population	_	_	NN	_	_	_	_	_
6	ageing	_	_	NN	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	major	_	_	JJ	_	_	_	_	_
9	reasons	_	_	NNS	_	_	_	_	_
10	for	_	_	IN	_	_	_	_	_
11	damage	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	failure	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	human	_	_	JJ	_	_	_	_	_
16	body	_	_	NN	_	_	_	_	_
17	tissues	_	_	NNS	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	organs	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	which	_	_	WDT	_	_	_	_	_
22	require	_	_	VBP	_	_	_	_	_
23	medical	_	_	JJ	_	_	_	_	_
24	treatments	_	_	NNS	_	_	_	_	_
25	for	_	_	IN	_	_	_	_	_
26	their	_	_	PRP$	_	_	_	_	_
27	restoration	_	_	NN	_	_	_	_	_
28	or	_	_	CC	_	_	_	_	_
29	replacement	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Despite	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	intrinsic	_	_	JJ	_	_	_	_	_
4	body	_	_	NN	_	_	_	_	_
5	capability	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	repairing	_	_	VBG	_	_	_	_	_
8	small	_	_	JJ	_	_	_	_	_
9	injuries	_	_	NNS	_	_	_	_	_
10	given	_	_	VBN	_	_	_	_	_
11	sufficient	_	_	JJ	_	_	_	_	_
12	time	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	date	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	tissue	_	_	NN	_	_	_	_	_
18	growth	_	_	NN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	large	_	_	JJ	_	_	_	_	_
21	(	_	_	-LRB-	_	_	_	_	_
22	centimeter-size	_	_	JJ	_	_	_	_	_
23	)	_	_	-RRB-	_	_	_	_	_
24	defects	_	_	NNS	_	_	_	_	_
25	requires	_	_	VBZ	_	_	_	_	_
26	complex	_	_	JJ	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	expensive	_	_	JJ	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	patient-painful	_	_	JJ	_	_	_	_	_
31	autografts	_	_	NNS	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	allografts	_	_	NNS	_	_	_	_	_
34	or	_	_	CC	_	_	_	_	_
35	xenografts	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	case	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	bone	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	autograft	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	allograft	_	_	NN	_	_	_	_	_
10	implantation	_	_	NN	_	_	_	_	_
11	produces	_	_	VBZ	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	best	_	_	JJS	_	_	_	_	_
14	clinical	_	_	JJ	_	_	_	_	_
15	results	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	but	_	_	CC	_	_	_	_	_
18	it	_	_	PRP	_	_	_	_	_
19	requires	_	_	VBZ	_	_	_	_	_
20	secondary	_	_	JJ	_	_	_	_	_
21	surgery	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	has	_	_	VBZ	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	limited	_	_	JJ	_	_	_	_	_
26	supply	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	main	_	_	JJ	_	_	_	_	_
3	advantage	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	xenograft	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	its	_	_	PRP$	_	_	_	_	_
9	abundant	_	_	JJ	_	_	_	_	_
10	supply	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	no	_	_	DT	_	_	_	_	_
13	need	_	_	NN	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	secondary	_	_	JJ	_	_	_	_	_
16	surgery	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	but	_	_	CC	_	_	_	_	_
19	poor	_	_	JJ	_	_	_	_	_
20	implantation	_	_	NN	_	_	_	_	_
21	results	_	_	NNS	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	problems	_	_	NNS	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	infection	_	_	NN	_	_	_	_	_
26	from	_	_	IN	_	_	_	_	_
27	donors	_	_	NNS	_	_	_	_	_
28	are	_	_	VBP	_	_	_	_	_
29	critical	_	_	JJ	_	_	_	_	_
30	issues	_	_	NNS	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Besides	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	neo-tissue	_	_	NN	_	_	_	_	_
5	generated	_	_	VBN	_	_	_	_	_
6	within	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	interstitial	_	_	JJ	_	_	_	_	_
9	spaces	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	these	_	_	DT	_	_	_	_	_
12	grafts	_	_	NNS	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	often	_	_	RB	_	_	_	_	_
15	different	_	_	JJ	_	_	_	_	_
16	from	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	native	_	_	JJ	_	_	_	_	_
19	tissue	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	requires	_	_	VBZ	_	_	_	_	_
22	large	_	_	JJ	_	_	_	_	_
23	remodeling	_	_	NN	_	_	_	_	_
24	time	_	_	NN	_	_	_	_	_
25	for	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	complete	_	_	JJ	_	_	_	_	_
28	biological	_	_	JJ	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	biomechanical	_	_	JJ	_	_	_	_	_
31	integration	_	_	NN	_	_	_	_	_
32	with	_	_	IN	_	_	_	_	_
33	surrounding	_	_	VBG	_	_	_	_	_
34	tissues	_	_	NNS	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	reasons	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	development	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	novel	_	_	JJ	_	_	_	_	_
9	solutions	_	_	NNS	_	_	_	_	_
10	for	_	_	IN	_	_	_	_	_
11	tissues	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	organs	_	_	NNS	_	_	_	_	_
14	bioengineering	_	_	NN	_	_	_	_	_
15	is	_	_	VBZ	_	_	_	_	_
16	extremely	_	_	RB	_	_	_	_	_
17	demanding	_	_	VBG	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	medical	_	_	JJ	_	_	_	_	_
21	field	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Tissue	_	_	NN	_	_	_	_	_
2	engineering	_	_	NN	_	_	_	_	_
3	(	_	_	-LRB-	_	_	_	_	_
4	TE	_	_	NNP	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	an	_	_	DT	_	_	_	_	_
8	important	_	_	JJ	_	_	_	_	_
9	biomedical	_	_	JJ	_	_	_	_	_
10	engineering	_	_	NN	_	_	_	_	_
11	field	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	aims	_	_	VBZ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	solve	_	_	VB	_	_	_	_	_
16	this	_	_	DT	_	_	_	_	_
17	important	_	_	JJ	_	_	_	_	_
18	challenge	_	_	NN	_	_	_	_	_
19	by	_	_	IN	_	_	_	_	_
20	combining	_	_	VBG	_	_	_	_	_
21	scaffolds	_	_	NNS	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	bioactive	_	_	JJ	_	_	_	_	_
24	molecules	_	_	NNS	_	_	_	_	_
25	for	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	artificial	_	_	JJ	_	_	_	_	_
28	reconstruction	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	functional	_	_	JJ	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	three-dimensional	_	_	JJ	_	_	_	_	_
33	(	_	_	-LRB-	_	_	_	_	_
34	3D	_	_	JJ	_	_	_	_	_
35	)	_	_	-RRB-	_	_	_	_	_
36	tissues	_	_	NNS	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	organs	_	_	NNS	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Biomedical	_	_	JJ	_	_	_	_	_
2	scaffolds	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	porous	_	_	JJ	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	implantable	_	_	JJ	_	_	_	_	_
7	biomaterials	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	shaped	_	_	VBN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	promptly	_	_	RB	_	_	_	_	_
12	restore	_	_	VB	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	natural	_	_	JJ	_	_	_	_	_
15	tissue	_	_	NN	_	_	_	_	_
16	anatomy	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	mechanical	_	_	JJ	_	_	_	_	_
19	functions	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	scaffolds	_	_	NNS	_	_	_	_	_
3	must	_	_	MD	_	_	_	_	_
4	also	_	_	RB	_	_	_	_	_
5	be	_	_	VB	_	_	_	_	_
6	capable	_	_	JJ	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	controlling	_	_	VBG	_	_	_	_	_
9	foreign	_	_	JJ	_	_	_	_	_
10	body	_	_	NN	_	_	_	_	_
11	reaction	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	new-tissue	_	_	JJ	_	_	_	_	_
14	formation	_	_	NN	_	_	_	_	_
15	by	_	_	IN	_	_	_	_	_
16	targeted	_	_	VBN	_	_	_	_	_
17	presentation	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	delivery	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	key	_	_	JJ	_	_	_	_	_
22	molecules	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	e.	_	_	FW	_	_	_	_	_
25	g.	_	_	FW	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	anti-inflammatory	_	_	JJ	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	growth	_	_	NN	_	_	_	_	_
30	factors	_	_	NNS	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	proteins	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	molecules	_	_	NNS	_	_	_	_	_
5	help	_	_	VBP	_	_	_	_	_
6	scaffolds	_	_	NNS	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	reduce	_	_	VB	_	_	_	_	_
9	inflammation	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	recruit	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	direct	_	_	JJ	_	_	_	_	_
14	differentiation	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	stem	_	_	NN	_	_	_	_	_
17	cells	_	_	NNS	_	_	_	_	_
18	from	_	_	IN	_	_	_	_	_
19	surrounding	_	_	VBG	_	_	_	_	_
20	tissues	_	_	NNS	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	ultimately	_	_	RB	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	promote	_	_	VB	_	_	_	_	_
25	functional	_	_	JJ	_	_	_	_	_
26	tissue	_	_	NN	_	_	_	_	_
27	integration	_	_	NN	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	situ	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Scaffolds	_	_	NNS	_	_	_	_	_
2	design	_	_	NN	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	fabrication	_	_	NN	_	_	_	_	_
5	have	_	_	VBP	_	_	_	_	_
6	evolved	_	_	VBN	_	_	_	_	_
7	greatly	_	_	RB	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	past	_	_	JJ	_	_	_	_	_
11	twenty	_	_	CD	_	_	_	_	_
12	years	_	_	NNS	_	_	_	_	_
13	due	_	_	JJ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	large	_	_	JJ	_	_	_	_	_
17	knowledge	_	_	NN	_	_	_	_	_
18	accumulated	_	_	VBN	_	_	_	_	_
19	on	_	_	IN	_	_	_	_	_
20	materials	_	_	NNS	_	_	_	_	_
21	design	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	processing	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	characterization	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	cell/scaffold	_	_	NN	_	_	_	_	_
28	interactions	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	natural	_	_	JJ	_	_	_	_	_
4	tissues	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	cells	_	_	NNS	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	extracellular	_	_	JJ	_	_	_	_	_
9	matrix	_	_	NN	_	_	_	_	_
10	(	_	_	-LRB-	_	_	_	_	_
11	ECM	_	_	NN	_	_	_	_	_
12	)	_	_	-RRB-	_	_	_	_	_
13	organize	_	_	VBP	_	_	_	_	_
14	into	_	_	IN	_	_	_	_	_
15	3D	_	_	JJ	_	_	_	_	_
16	structures	_	_	NNS	_	_	_	_	_
17	from	_	_	IN	_	_	_	_	_
18	sub-cellular	_	_	JJ	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	tissue	_	_	NN	_	_	_	_	_
21	level	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Consequently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	engineer	_	_	VB	_	_	_	_	_
5	functional	_	_	JJ	_	_	_	_	_
6	tissues	_	_	NNS	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	organs	_	_	NNS	_	_	_	_	_
9	successfully	_	_	RB	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	scaffolds	_	_	NNS	_	_	_	_	_
12	must	_	_	MD	_	_	_	_	_
13	capture	_	_	VB	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	essence	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	this	_	_	DT	_	_	_	_	_
18	cells/ECM	_	_	NN	_	_	_	_	_
19	organization	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	must	_	_	MD	_	_	_	_	_
22	provide	_	_	VB	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	porous	_	_	JJ	_	_	_	_	_
25	structure	_	_	NN	_	_	_	_	_
26	able	_	_	JJ	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	facilitate	_	_	VB	_	_	_	_	_
29	cells	_	_	NNS	_	_	_	_	_
30	distribution	_	_	NN	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	guide	_	_	VB	_	_	_	_	_
33	3D	_	_	JJ	_	_	_	_	_
34	tissue	_	_	NN	_	_	_	_	_
35	regeneration	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Scaffolds	_	_	NNS	_	_	_	_	_
2	pore	_	_	NN	_	_	_	_	_
3	size	_	_	NN	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	shape	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	pore	_	_	NN	_	_	_	_	_
8	wall	_	_	NN	_	_	_	_	_
9	morphology	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	porosity	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	surface	_	_	NN	_	_	_	_	_
14	area	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	pore	_	_	NN	_	_	_	_	_
17	interconnectivity	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	are	_	_	VBP	_	_	_	_	_
20	probably	_	_	RB	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	most	_	_	RBS	_	_	_	_	_
23	important	_	_	JJ	_	_	_	_	_
24	architectural	_	_	JJ	_	_	_	_	_
25	parameters	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	as	_	_	IN	_	_	_	_	_
28	they	_	_	PRP	_	_	_	_	_
29	have	_	_	VBP	_	_	_	_	_
30	been	_	_	VBN	_	_	_	_	_
31	shown	_	_	VBN	_	_	_	_	_
32	to	_	_	TO	_	_	_	_	_
33	directly	_	_	RB	_	_	_	_	_
34	impact	_	_	VB	_	_	_	_	_
35	cells	_	_	NNS	_	_	_	_	_
36	migration	_	_	NN	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	colonization	_	_	NN	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	new	_	_	JJ	_	_	_	_	_
41	ECM	_	_	NN	_	_	_	_	_
42	biosynthesis	_	_	NN	_	_	_	_	_
43	and	_	_	CC	_	_	_	_	_
44	organization	_	_	NN	_	_	_	_	_
45	,	_	_	,	_	_	_	_	_
46	oxygen	_	_	NN	_	_	_	_	_
47	and	_	_	CC	_	_	_	_	_
48	nutrients	_	_	NNS	_	_	_	_	_
49	transport	_	_	NN	_	_	_	_	_
50	to	_	_	TO	_	_	_	_	_
51	cells	_	_	NNS	_	_	_	_	_
52	,	_	_	,	_	_	_	_	_
53	as	_	_	RB	_	_	_	_	_
54	well	_	_	RB	_	_	_	_	_
55	as	_	_	IN	_	_	_	_	_
56	metabolic	_	_	JJ	_	_	_	_	_
57	wastes	_	_	NNS	_	_	_	_	_
58	removal	_	_	NN	_	_	_	_	_
59	in	_	_	IN	_	_	_	_	_
60	the	_	_	DT	_	_	_	_	_
61	whole	_	_	JJ	_	_	_	_	_
62	cell/scaffold	_	_	NN	_	_	_	_	_
63	construct	_	_	NN	_	_	_	_	_
64	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	scaffold	_	_	NN	_	_	_	_	_
3	material	_	_	NN	_	_	_	_	_
4	must	_	_	MD	_	_	_	_	_
5	be	_	_	VB	_	_	_	_	_
6	selected	_	_	VBN	_	_	_	_	_
7	and/or	_	_	NN	_	_	_	_	_
8	designed	_	_	VBN	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	degradation	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	resorption	_	_	NN	_	_	_	_	_
14	rate	_	_	NN	_	_	_	_	_
15	such	_	_	JJ	_	_	_	_	_
16	that	_	_	IN	_	_	_	_	_
17	scaffold	_	_	NN	_	_	_	_	_
18	strength	_	_	NN	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	retained	_	_	VBN	_	_	_	_	_
21	until	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	tissue-engineered	_	_	JJ	_	_	_	_	_
24	transplant	_	_	NN	_	_	_	_	_
25	is	_	_	VBZ	_	_	_	_	_
26	fully	_	_	RB	_	_	_	_	_
27	remodeled	_	_	VBN	_	_	_	_	_
28	by	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	host	_	_	NN	_	_	_	_	_
31	tissue	_	_	NN	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	can	_	_	MD	_	_	_	_	_
34	assume	_	_	VB	_	_	_	_	_
35	its	_	_	PRP$	_	_	_	_	_
36	own	_	_	JJ	_	_	_	_	_
37	structural	_	_	JJ	_	_	_	_	_
38	role	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	More	_	_	RBR	_	_	_	_	_
2	importantly	_	_	RB	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	controlling	_	_	VBG	_	_	_	_	_
5	mechanical	_	_	JJ	_	_	_	_	_
6	properties	_	_	NNS	_	_	_	_	_
7	at	_	_	IN	_	_	_	_	_
8	cellular	_	_	JJ	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	sub-cellular	_	_	JJ	_	_	_	_	_
11	levels	_	_	NNS	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	important	_	_	JJ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	emulate	_	_	VB	_	_	_	_	_
16	as	_	_	RB	_	_	_	_	_
17	closely	_	_	RB	_	_	_	_	_
18	as	_	_	IN	_	_	_	_	_
19	possible	_	_	JJ	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	vivo	_	_	NN	_	_	_	_	_
23	cell	_	_	NN	_	_	_	_	_
24	behavior	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	tissue	_	_	NN	_	_	_	_	_
27	growth	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Nevertheless	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	controlling	_	_	VBG	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	morphological	_	_	JJ	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	biomechanical	_	_	JJ	_	_	_	_	_
8	properties	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	porous	_	_	JJ	_	_	_	_	_
11	scaffolds	_	_	NNS	_	_	_	_	_
12	is	_	_	VBZ	_	_	_	_	_
13	not	_	_	RB	_	_	_	_	_
14	enough	_	_	JJ	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	success	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	scaffolds-based	_	_	JJ	_	_	_	_	_
20	therapies	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	as	_	_	IN	_	_	_	_	_
23	there	_	_	EX	_	_	_	_	_
24	is	_	_	VBZ	_	_	_	_	_
25	also	_	_	RB	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	need	_	_	NN	_	_	_	_	_
28	to	_	_	TO	_	_	_	_	_
29	load	_	_	VB	_	_	_	_	_
30	matricellular	_	_	JJ	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	soluble	_	_	JJ	_	_	_	_	_
33	molecules	_	_	NNS	_	_	_	_	_
34	inside	_	_	IN	_	_	_	_	_
35	scaffolds	_	_	NNS	_	_	_	_	_
36	’	_	_	POS	_	_	_	_	_
37	matrix	_	_	NN	_	_	_	_	_
38	as	_	_	IN	_	_	_	_	_
39	biochemical	_	_	JJ	_	_	_	_	_
40	regulators	_	_	NNS	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	cells	_	_	NNS	_	_	_	_	_
43	behavior	_	_	NN	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	reported	_	_	VBN	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	porous	_	_	JJ	_	_	_	_	_
8	scaffolds	_	_	NNS	_	_	_	_	_
9	releasing	_	_	VBG	_	_	_	_	_
10	biochemical	_	_	JJ	_	_	_	_	_
11	signals	_	_	NNS	_	_	_	_	_
12	following	_	_	VBG	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	precise	_	_	JJ	_	_	_	_	_
15	dose	_	_	NN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	time	_	_	NN	_	_	_	_	_
18	intervals	_	_	NNS	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	target	_	_	VB	_	_	_	_	_
21	sites	_	_	NNS	_	_	_	_	_
22	stimulate	_	_	VBP	_	_	_	_	_
23	cells	_	_	NNS	_	_	_	_	_
24	’	_	_	POS	_	_	_	_	_
25	functions	_	_	NNS	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	e.	_	_	FW	_	_	_	_	_
28	g.	_	_	FW	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	adhesion	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	proliferation	_	_	NN	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	migration	_	_	NN	_	_	_	_	_
35	)	_	_	-RRB-	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	promote	_	_	VB	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	biosynthesis	_	_	NN	_	_	_	_	_
40	of	_	_	IN	_	_	_	_	_
41	new	_	_	JJ	_	_	_	_	_
42	ECM	_	_	NN	_	_	_	_	_
43	and	_	_	CC	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	ultimately	_	_	RB	_	_	_	_	_
46	,	_	_	,	_	_	_	_	_
47	guide	_	_	VB	_	_	_	_	_
48	tissue	_	_	NN	_	_	_	_	_
49	growth	_	_	NN	_	_	_	_	_
50	,	_	_	,	_	_	_	_	_
51	morphogenesis	_	_	NN	_	_	_	_	_
52	and	_	_	CC	_	_	_	_	_
53	vascularization	_	_	NN	_	_	_	_	_
54	.	_	_	.	_	_	_	_	_


1	Increasing	_	_	VBG	_	_	_	_	_
2	scaffolds	_	_	NNS	_	_	_	_	_
3	’	_	_	POS	_	_	_	_	_
4	design	_	_	NN	_	_	_	_	_
5	complexity	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	therefore	_	_	RB	_	_	_	_	_
8	extremely	_	_	RB	_	_	_	_	_
9	demanding	_	_	JJ	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	scientists	_	_	NNS	_	_	_	_	_
12	face	_	_	VBP	_	_	_	_	_
13	some	_	_	DT	_	_	_	_	_
14	important	_	_	JJ	_	_	_	_	_
15	challenges	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	such	_	_	JJ	_	_	_	_	_
18	as	_	_	IN	_	_	_	_	_
19	:	_	_	:	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	1	_	_	CD	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	engineering	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	scaffold	_	_	NN	_	_	_	_	_
26	microarchitecture	_	_	NN	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	mimic	_	_	VB	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	ECM	_	_	NN	_	_	_	_	_
31	structure	_	_	NN	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	(	_	_	-LRB-	_	_	_	_	_
34	2	_	_	CD	_	_	_	_	_
35	)	_	_	-RRB-	_	_	_	_	_
36	imprinting	_	_	VBG	_	_	_	_	_
37	topological	_	_	JJ	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	biochemical	_	_	JJ	_	_	_	_	_
40	patterns	_	_	NNS	_	_	_	_	_
41	inside	_	_	IN	_	_	_	_	_
42	scaffolds	_	_	NNS	_	_	_	_	_
43	pores	_	_	NNS	_	_	_	_	_
44	to	_	_	TO	_	_	_	_	_
45	guide	_	_	VB	_	_	_	_	_
46	cells	_	_	NNS	_	_	_	_	_
47	’	_	_	POS	_	_	_	_	_
48	growth	_	_	NN	_	_	_	_	_
49	and	_	_	CC	_	_	_	_	_
50	tissue	_	_	NN	_	_	_	_	_
51	morphogenesis	_	_	NN	_	_	_	_	_
52	,	_	_	,	_	_	_	_	_
53	and	_	_	CC	_	_	_	_	_
54	(	_	_	-LRB-	_	_	_	_	_
55	3	_	_	CD	_	_	_	_	_
56	)	_	_	-RRB-	_	_	_	_	_
57	developing	_	_	VBG	_	_	_	_	_
58	automated	_	_	JJ	_	_	_	_	_
59	processes	_	_	NNS	_	_	_	_	_
60	for	_	_	IN	_	_	_	_	_
61	the	_	_	DT	_	_	_	_	_
62	precise	_	_	JJ	_	_	_	_	_
63	and	_	_	CC	_	_	_	_	_
64	reliable	_	_	JJ	_	_	_	_	_
65	control	_	_	NN	_	_	_	_	_
66	of	_	_	IN	_	_	_	_	_
67	scaffolds	_	_	NNS	_	_	_	_	_
68	’	_	_	POS	_	_	_	_	_
69	features	_	_	NNS	_	_	_	_	_
70	and	_	_	CC	_	_	_	_	_
71	geometry	_	_	NN	_	_	_	_	_
72	.	_	_	.	_	_	_	_	_


1	Porous	_	_	JJ	_	_	_	_	_
2	bioactive	_	_	JJ	_	_	_	_	_
3	scaffolds	_	_	NNS	_	_	_	_	_
4	can	_	_	MD	_	_	_	_	_
5	be	_	_	VB	_	_	_	_	_
6	fabricated	_	_	VBN	_	_	_	_	_
7	by	_	_	IN	_	_	_	_	_
8	combining	_	_	VBG	_	_	_	_	_
9	biomaterials	_	_	NNS	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	growth	_	_	NN	_	_	_	_	_
12	factors	_	_	NNS	_	_	_	_	_
13	through	_	_	IN	_	_	_	_	_
14	different	_	_	JJ	_	_	_	_	_
15	processing	_	_	NN	_	_	_	_	_
16	techniques	_	_	NNS	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	review	_	_	NN	_	_	_	_	_
3	focuses	_	_	VBZ	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	attention	_	_	NN	_	_	_	_	_
6	on	_	_	IN	_	_	_	_	_
7	modular	_	_	JJ	_	_	_	_	_
8	approaches	_	_	NNS	_	_	_	_	_
9	where	_	_	WRB	_	_	_	_	_
10	samples	_	_	NNS	_	_	_	_	_
11	are	_	_	VBP	_	_	_	_	_
12	built	_	_	VBN	_	_	_	_	_
13	by	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	“	_	_	``	_	_	_	_	_
16	bottom-up	_	_	JJ	_	_	_	_	_
17	”	_	_	''	_	_	_	_	_
18	assembly	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	smaller	_	_	JJR	_	_	_	_	_
21	units	_	_	NNS	_	_	_	_	_
22	or	_	_	CC	_	_	_	_	_
23	“	_	_	``	_	_	_	_	_
24	modules	_	_	NNS	_	_	_	_	_
25	”	_	_	''	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	each	_	_	DT	_	_	_	_	_
28	one	_	_	CD	_	_	_	_	_
29	specifically	_	_	RB	_	_	_	_	_
30	designed	_	_	VBN	_	_	_	_	_
31	for	_	_	IN	_	_	_	_	_
32	distinct	_	_	JJ	_	_	_	_	_
33	tasks	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Bottom	_	_	JJ	_	_	_	_	_
2	up	_	_	RP	_	_	_	_	_
3	approaches	_	_	NNS	_	_	_	_	_
4	have	_	_	VBP	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	potential	_	_	NN	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	build	_	_	VB	_	_	_	_	_
9	scaffolds	_	_	NNS	_	_	_	_	_
10	mimicking	_	_	VBG	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	complex	_	_	JJ	_	_	_	_	_
13	molecular	_	_	JJ	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	structural	_	_	JJ	_	_	_	_	_
16	microenvironment	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	native	_	_	JJ	_	_	_	_	_
20	ECM	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	every	_	_	DT	_	_	_	_	_
23	kind	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	tissues	_	_	NNS	_	_	_	_	_
26	by	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	proper	_	_	JJ	_	_	_	_	_
29	assembly	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	micro-	_	_	JJ	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	nano-structured	_	_	JJ	_	_	_	_	_
34	modules	_	_	NNS	_	_	_	_	_
35	with	_	_	IN	_	_	_	_	_
36	well-defined	_	_	JJ	_	_	_	_	_
37	morphological	_	_	JJ	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	biochemical	_	_	JJ	_	_	_	_	_
40	properties	_	_	NNS	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_

